Related references
Note: Only part of the references are listed.The potential role of Akt phosphorylation in human cancers
J. Cicenas
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
European cancer mortality predictions for the year 2016 with focus on leukaemias
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2016)
Pancreatic cancer screening using a multiplatform human serum metabolomics system
Arata Sakai et al.
BIOMARKERS IN MEDICINE (2016)
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
Farshad Farshidfar et al.
BRITISH JOURNAL OF CANCER (2016)
Current Role of Proteomics in Pancreatic Cancer Biomarkers Research
Audrius Sileikis et al.
CURRENT PROTEOMICS (2016)
Multi-kinase inhibitors, AURKs and cancer
Jonas Cicenas et al.
MEDICAL ONCOLOGY (2016)
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
Ana Rita Lima et al.
TRANSLATIONAL ONCOLOGY (2016)
Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis
Xiaoli Zhang et al.
ONCOTARGET (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma
Joseph J. LaConti et al.
BMC GENOMICS (2015)
Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC
Jinfeng Xiang et al.
CANCER LETTERS (2015)
Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling
Paul T. Fullerton et al.
MOLECULAR ENDOCRINOLOGY (2015)
Metabolic Phenotypes in Pancreatic Cancer
Min Yu et al.
PLOS ONE (2015)
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters
Shiro Urayama
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Yasuki Hori et al.
PLOS ONE (2015)
A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile
Nobuyasu Fukutake et al.
PLOS ONE (2015)
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
Jared R. Mayers et al.
NATURE MEDICINE (2014)
Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
Mary Jo Cantoria et al.
METABOLOMICS (2014)
Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra- Day Variation in Patients with Advanced Pancreatic Cancer
Yutaka Fujiwara et al.
PLOS ONE (2014)
Is Additional Enrichment of Diet in Branched-Chain Amino Acids or Glutamine Beneficial for Patients Receiving Total Parenteral Nutrition after Gastrointestinal Cancer Surgery?
Maria Szpetnar et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2014)
Pancreatic Ductal Adenocarcinoma is Associated with a Distinct Urinary Metabolomic Signature
Vanessa W. Davis et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer
Takashi Kobayashi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer
Geng Zhang et al.
CLINICAL CANCER RESEARCH (2013)
p53 status determines the role of autophagy in pancreatic tumour development
Mathias T. Rosenfeldt et al.
NATURE (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma
Alexander Benedikt Leichtle et al.
METABOLOMICS (2013)
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)
E. J. Duell et al.
ANNALS OF ONCOLOGY (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by 1H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution
Claudia Napoli et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75
Diane M. Harris et al.
METABOLOMICS (2012)
Utility of Nuclear Magnetic Resonance Spectroscopy for Pancreatic Cancer Studies
Yasvir A. Tesiram et al.
PANCREAS (2012)
Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
Oliver F. Bathe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
Robert R. McWilliams et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles
Masahiro Sugimoto et al.
METABOLOMICS (2010)
Metabolomics reviewed: A new Omics platform technology for systems biology and implications for natural products research
S Rochfort
JOURNAL OF NATURAL PRODUCTS (2005)
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics
K Odunsi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
J Cicenas et al.
BREAST CANCER RESEARCH (2005)
Overexpression of the nuclear receptor coactivator AIB1, (SRC-3) during progression of pancreatic adenocarcinoma
RT Henke et al.
CLINICAL CANCER RESEARCH (2004)
Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases
J Yang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness - Poor prognosis in patients with pancreatic ductal adenocarcinoma
S Ueda et al.
PANCREAS (2004)
Share Paper
